AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Holders of 5% or more of AIM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of AIM ImmunoTech Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of AIM ImmunoTech Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on AIM ImmunoTech Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20254:55 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%3.35M shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 23, 202411:11 AM ET | Deutsch Toddand 3 others | 13D/A | 2.70%1.72M shares | –Below 5% | Dec 19, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell AIM ImmunoTech Inc. shares.
No Form 144 notices for AIM ImmunoTech Inc. are on file.